Bringing the fundamentals into focus…
Back to Bristol-Myers Squibb Company
How Bristol-Myers Squibb Company stacks up
BMY · against 454 other Healthcare companies listed in US-listed
Growth
63/ 100
Below the middle of the pack.
Ranked #234 of 455 · scores higher than 48% of peers
Bars: peers in each 10-point band of the growth score46 peers with a growth score of 60–69, including BMY · Click a bar to see the companies
Why growth scores 63?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth, which is stronger than most Healthcare peers.
- slower revenue growth over three years: weaker than 63% of peers. 3-year revenue growth: 2.9% vs peer median 5.8%
- Revenue growth is close to the peer norm. Revenue growth: 3.1% vs peer median 6.1%
- faster growth in earnings per share: stronger than 84% of peers. Earnings per share growth: 83.2% vs peer median 9.8%
Metric by metric
Position: dot = BMY, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BMY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 3.1% | 11.0% | 28% | 33% | |
| Earnings per share growthHigher is better · 171 reported | 83.2% | 21.2% | 79% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | 2.9% | 11.0% | 26% | 33% |
Ranking by growth score
Top 5 and the companies ranked around BMY| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 229 | 255M USD | 64 | 36 | |
| 229 | 2.5B USD | 64 | 31 | |
| 234 | 249.4B USD | 63 | 55 | |
| 234 | 487M USD | 63 | 24 | |
| 234 | 126.1B USD | 63 | 62 | |
| 234 | 5.1B USD | 63 | 54 | |
| 234 | 1.6B USD | 63 | 24 | |
| 239 | 1.5B USD | 62 | 26 | |
| 239 | 221M USD | 62 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score